Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA)

A Resource for Healthcare and Social Services Professionals

Novel Opioid Overdose Prevention Strategies

April 16, 2021
12:00 pm–1:30 pm ET

The basics of overdose education and response will be reviewed. The care of patients who have a history of overdose to prevent additional overdose will be discussed. The training will review the efficacy of bystander overdose education and prevention. Novel strategies including test strips, sedation monitoring centers, safe consumption sites, and safe supply will be discussed along with the legality in the US. The pharmacology of nasal naloxone and the physiological implications of opioid blockade will be reviewed. Harm reduction strategies related to polysubstance use and when “the Narcan is just not enough” will be explored.

PLEASE NOTE: This training will be held over Zoom.

Register now

Virtual meeting

Via Zoom

Description

The Harm Reduction Series is designed to provide care givers and providers with information on best practices for caring for individuals who are actively using substances. The education series will teach ways to expand the treatment continuum to include engaging and keeping people safe when they are actively using substances including alcohol, opioids, stimulants, and tobacco. The series is designed for a broad range of audiences and each module will be presented with an expert from the community to provide insight regarding strategies for engagement and implementation.

The basics of overdose education and response will be reviewed. The care of patients who have a history of overdose to prevent additional overdose will be discussed. The training will review the efficacy of bystander overdose education and prevention. Novel strategies including test strips, sedation monitoring centers, safe consumption sites, and safe supply will be discussed along with the legality in the US. The pharmacology of nasal naloxone and the physiological implications of opioid blockade will be reviewed. Harm reduction strategies related to polysubstance use and when “the Narcan is just not enough” will be explored.

 

Intended audience

The entire multidisciplinary team providing treatment for substance use disorders in an office-based setting as well as anyone in a clinical or non-clinical position that is interested in learning about harm reduction.

Guest Speaker

Glory Ruiz, MD Director of Public Health Programs at Boston Medical Center

Speakers

Vanessa Loukas, MSN, FNP-C, CARN-AP Glory Ruiz, MD

Director of Public Health Programs at Boston Medical Center

Objectives

Sponsored by

Boston Medical Center Grayken Center for Addiction, Department of Public Health, Bureau of Substance Addiction Services.

Accreditation information

Boston Medical Center grants 1.50 hours to all RNS who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Boston University School of Medicine designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston University School of Social Work which is authorized through the MA state board of Social Work to provide 1.50 CE Credit Hours.

Massachusetts Mental Health Counselors Association, Inc. (MaMHCA) grants 1.50 LMHC CE Credits to LMHCs that attend this activity.

Register now

OBAT TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for OBAT TTA is provided by:

Commonwealth of Massachusetts Department of Public Health
Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation

© 2021 Boston Medical Center. All rights reserved. Site by Signal.